1. Market Research
  2. > Biotechnology
  3. > Biopharmaceutical Market Trends
  4. > Drug Delivery - Innovations, trends, and their impact on pharma

Drug Delivery - Innovations, trends, and their impact on pharma

  • November 2015
  • -
  • Firstword Pharma


Table of Contents

Why you need Drug Delivery - Innovations, trends, and their impact on pharma

Revolutionary changes are disrupting the status quo simply through developments in the way drugs are given to patients. In a rapidly evolving field, drug delivery systems are offering growth opportunities and solutions – as well as presenting difficulties – as the range of choices grows.

To make sure you don't get left behind you need to understand what is happening at the cutting edge from experts innovating and leading the way through the technological and regulatory minefield. See how companies like Sanofi, Surefire Medical and Invion among other market leaders explain how they see the market and how they are dealing with the challenges.

Top Takeaways:

Change is accelerating. There's a wide range of new products at late-stage development, 200+ partnership deals are signed each year and device companies are now entering the market directly
Reliance on delivery mechanisms is increasing as health economics requirements on efficacy and cost-effectiveness multiply
Significant delivery mechanism opportunities still exist with the potential to solve unmet needs with new formulations
Drug combinations offer risks and rewards – the promise of innovative formulas is potentially hampered by technology and regulation
Product franchises are protected by differentiating products and by extending a profitable drug's lifecycle
Opportunities are growing in new markets as the Far East opens up and China expands healthcare to the wider population

Key Issues Explored

Key drivers and how devices are transforming the market including oral medicines, inhalers, injectable devices, patches, subdermal implants, neurostimulation and smart devices
The challenges faced in choosing and developing the right delivery system and formulations, looking at biopharmaceuticals, biologics, excipients, large and small molecules, peptides, proteins and biosimilars
Hurdles to commercialisation globally – how companies are evolving strategies to deal with local regulatory issues for global products
Improving patient compliance with better outcomes and the potential for home-based care offered by some systems
The value of overcoming technical challenges before clinical trials begin
The cost-benefit considerations of different development models including outsourcing, partnerships and internal development.
The impact of health economics on innovation in the drug delivery market, reimbursement concerns and access issues

Who needs this report?

Presidents and VPs of product development – to see the drugs and devices in the pipeline and the potential opportunities and risks involved
Business development directors – to get support and improve and refine strategic direction and decisions
Device development team managers – to see expansion possibilities and the current state of the competitive market
Delivery and formulation specialists – to analyse current best practice
Manufacturers of devices – to see the top drug delivery partnerships and get an overview of growth prospects
Insurers and payers – to gain insights into the value of more effective delivery mechanisms to ensure the best use of limited resources
Big data companies and electronic health companies – to see current and future developments in connected devices


Director, Drug Delivery Technologies, European Pharma Company,
Vice President, Medical Device Development, Global pharma Company
Igor Gonda: President & CEO, Aradigm Corporation [Linkedin]
Jeff Macdonald: Senior Director, Corporate Communications, Acorda Therapeutics
Seth Yakatan: CSO, Vice President of Business Development, Invion Group
Director, Corporate Development, Respiratory Product Development Company
Director, Pharmaceutical Sciences, Respiratory Product Development Company Douglas Marenzi: CEO, PHC Technologies
David Urquhart: Business Development, PHC Technologies
Morten Nielsen: CEO, Medicom Innovation Partner
Frédéric Gabriel: CSO and General Manager, Haselmeier
Jim Chomas Ph.D: President and CEO, Surefire Medical
Norman Weldon: Chairman, SureFire Medical
Julian Chick, Ph.D: COO, Admedus Ltd
JP Errico, Ph.D: CEO, electroCore Medical

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Global Markets for Protein Labeling

Global Markets for Protein Labeling

  • $ 6650
  • Industry report
  • February 2017
  • by BCC Research

Use this report to: - Identify key market dynamics and the factors impacting the global protein-labeling market and its subsegments. - Gain insight into global protein-labeling market and its market segments, ...

Global Laboratory Products Purchasing Trends, 2016–2017

Global Laboratory Products Purchasing Trends, 2016–2017

  • $ 6000
  • Industry report
  • December 2016
  • by Frost & Sullivan

An End-user Perspective on the Purchasing Process, Product Budgets, and Top Companies for Laboratory Products Readers of Lab Manager Magazine were invited to participate in an online survey in July 2016. ...

Biosimilars Market by Product, Manufacturing, Application - Global Forecast to 2021

Biosimilars Market by Product, Manufacturing, Application - Global Forecast to 2021

  • $ 5650
  • Industry report
  • January 2017
  • by MarketsandMarkets

Biosimilars Market by Product (Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon), glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin)), Manufacturing (In-House, CM0) & Application ...


Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.